1-7 of 7
Barry Turnbull
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Clinical Trials & Observations
Ian W. Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Árpád Illés, Gabriel Etienne, Julio Delgado, Bryone J. Kuss, Constantine S. Tam, Zoltán Gasztonyi, Fritz Offner, Scott Lunin, Francesco Bosch, Matthew S. Davids, Nicole Lamanna, Ulrich Jaeger, Paolo Ghia, Florence Cymbalista, Craig A. Portell, Alan P. Skarbnik, Amanda F. Cashen, David T. Weaver, Virginia M. Kelly, Barry Turnbull, Stephan Stilgenbauer
Journal: Blood
Blood (2018) 132 (23): 2446–2455.
https://doi.org/10.1182/blood-2018-05-850461
Published: 2018
Includes: Supplemental data
Journal Articles

Results from the Phase 3 DUO TM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Ian W. Flinn, MD PhD, Peter Hillmen, MBChB, PhD, Marco Montillo, MD, Zsolt Nagy, MD PhD, Árpád Illés, MD PhD, Gabriel Etienne, MD PhD, Julio Delgado, MD, Bryone Jean Kuss, PhDBMBS,FRCPA,FRACP, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Zoltán Gasztonyi, MD, Fritz Offner, MD, Scott D Lunin, MD, Francesco Bosch, MD, Matthew S. Davids, MD MMSc, Nicole Lamanna, MD, Ulrich Jaeger, MD, Paolo Ghia, Florence Cymbalista, MD, Craig A. Portell, MD, Alan P Skarbnik, MD, Amanda Cashen, MD, Virginia Kelly, MD, Barry Turnbull, PhD, Stephan Stilgenbauer, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 493.
https://doi.org/10.1182/blood.V130.Suppl_1.493.493
Published: 2017
Journal Articles

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia

Clinical Trials & Observations
Steven P. Treon, Christina K. Tripsas, Kirsten Meid, Sandra Kanan, Patricia Sheehy, Stacey Chuma, Lian Xu, Yang Cao, Guang Yang, Xia Liu, Christopher J. Patterson, Diane Warren, Zachary R. Hunter, Barry Turnbull, Irene M. Ghobrial, Jorge J. Castillo
Journal: Blood
Blood (2014) 124 (4): 503–510.
https://doi.org/10.1182/blood-2014-03-566273
Published: 2014
Journal Articles

Treatment with a Bortezomib-Containing Regimen Is Associated with Better Therapeutic Outcomes in Patients with Waldenstrom's Macroglobulinemia Who Have Familial Disease Predisposition

Steven P Treon, MD, PhD, Zachary Hunter, Christina Hanzis, Christina Tripsas, Leukothea Ioakimidis, Christopher Patterson, Robert Manning, Patricia Sheehy, NP, Barry Turnbull, PhD
Journal: Blood
Blood (2011) 118 (21): 1643.
https://doi.org/10.1182/blood.V118.21.1643.1643
Published: 2011
Journal Articles

Maintenance Rituximab Is Associated with Improved Progression Free and Overall Survival in Waldenstrom's Macroglobulinemia.

Steven P Treon, MD, PhD, Christina Hanzis, Robert Manning, Thea Ioakimidis, MS, Christopher J Patterson, Zachary Hunter, Barry Turnbull, PhD, Patricia Sheehy, NP
Journal: Blood
Blood (2009) 114 (22): 3750.
https://doi.org/10.1182/blood.V114.22.3750.3750
Published: 2009
Journal Articles

Progression Free Survival Is Predicated by Categorical Response, and Supports the Attainment of VGPR/CR as An Objective for Long Term Disease Control in Waldenstrom's Macroglobulinemia.

Steven Treon, MD, PhD, Thea Ioakimidis, MS, Christina Hanzis, Robert Manning, Christopher J Patterson, Zachary Hunter, Patricia Sheehy, NP, Barry Turnbull, PhD
Journal: Blood
Blood (2009) 114 (22): 4993.
https://doi.org/10.1182/blood.V114.22.4993.4993
Published: 2009
Journal Articles

Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia

Clinical Trials & Observations
Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, Eva Kimby
Journal: Blood
Blood (2009) 113 (16): 3673–3678.
https://doi.org/10.1182/blood-2008-09-177329
Published: 2009